Mode
Text Size
Log in / Sign up

Cutaneous melanoma

Part of Cancer

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Cutaneous melanoma

7 trials tracked for Cutaneous melanoma.

7Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 5 Other / NA 2
  1. Phase 2 Neoadjuvant and Adjuvant Checkpoint Blockade Completed
  2. Phase 2 Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma Completed
  3. Phase 2 A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1). Completed
  4. Phase 2 Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma Completed
  5. Phase 2 A Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV Melanoma Completed
  6. N/A Enhancing Skin Cancer Early Detection and Treatment in Primary Care Completed
Show 1 more trials
  1. N/A Confirmatory Trial in the Evaluation of Ca Electroporation for the Treatment of Cutaneous Metastases Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Cancer

Related studies from across the Cancer family.

AI-assisted clinicians achieve 1.000 sensitivity in melanoma diagnosis but autonomous AI lacks clear clinical advantage
Rheumatology Meta-analysis
AI-assisted clinicians achieve 1.000 sensitivity in melanoma diagnosis but autonomous AI lacks clear clinical advantage Artificial Intelligence Shows Mixed Results in Detecting Melanoma
This meta-analysis of 17 diagnostic arms from 10 studies evaluates artificial intelligence for dermoscopic image analysis in melanoma detect…
New research shows that while AI can help identify skin cancer, it does not yet outperform traditional methods used by doctors.
Opsin 3 serves as a potential therapeutic target for melanoma and inflammatory skin diseases
Rheumatology Sys. Review
Opsin 3 serves as a potential therapeutic target for melanoma and inflammatory skin diseases Opsin 3 May Offer New Path for Skin Disease Treatment
This narrative review explores the role of Opsin 3 (OPN3) in skin pathophysiology, including its involvement in UV damage, melanoma developm…
A protein called Opsin 3 may play a key role in how skin cells respond to UV damage, aging, and inflammation.
AI diagnostic tools show high accuracy but limited real-world validation in systematic review
Oncology Meta-analysis
AI diagnostic tools show high accuracy but limited real-world validation in systematic review Artificial intelligence shows high accuracy in detecting various medical conditions
This systematic review of 24 studies synthesizes evidence on AI and deep learning for disease detection across multiple imaging modalities. …
New analysis of 24 studies shows AI tools can reach over 90% accuracy in spotting everything from lung cancer to skin disorders.
Actinic keratosis increases melanoma risk while alcohol consumption is associated with lower squamous cell carcinoma risk
Genetics & Precision Medicine Meta-analysis
Actinic keratosis increases melanoma risk while alcohol consumption is associated with lower squamous cell carcinoma risk Actinic Keratosis Linked to Higher Risk of Melanoma
This meta-analysis of genome-wide association studies evaluates causal relationships between 11 modifiable risk factors and skin cancers. Th…
New research identifies a link between actinic keratosis and melanoma risk while highlighting potential new targets for skin cancer treatmen…
Sugar sweetened beverages and orange juice are associated with increased risk of several cancer types
Nutrition & Obesity Medicine Sys. Review
Sugar sweetened beverages and orange juice are associated with increased risk of several cancer types Sugar sweetened drinks may increase risk of several cancer types
This meta-analysis of 51 cohort studies evaluates the link between sugar sweetened beverages (SSBs), artificially sweetened beverages (ASBs)…
New research suggests a link between sugar-sweetened beverages and an increased risk of certain cancers, including pancreatic and colorectal…
Targeted cytokine delivery platforms in canine oncology provide data for human immuno-oncology dose selection
Allergy & Immunology Sys. Review
Targeted cytokine delivery platforms in canine oncology provide data for human immuno-oncology dose selection Cytokine Therapies Show Potential for Treating Canine Cancers
This mini review synthesizes evidence on targeted cytokine delivery platforms, such as IL-12 and IFN-beta, in dogs with various spontaneous …
New research explores how targeted cytokine delivery systems can treat various cancers in dogs and provide data for future human cancer trea…
IO102-IO103 plus pembrolizumab improves progression-free survival in advanced melanoma patients
Dermatology RCT
IO102-IO103 plus pembrolizumab improves progression-free survival in advanced melanoma patients Trial shows combination therapy may extend time before melanoma progresses
This Phase III randomized controlled trial of 407 patients with untreated advanced melanoma evaluated IO102-IO103 (85 μg) combined with pemb…
A new clinical trial suggests that combining two specific drugs may help patients with advanced melanoma stay stable for longer periods.
Motivation-informed digital reminders do not improve task completion compared to standard wording in melanoma trial
Dermatology RCT
Motivation-informed digital reminders do not improve task completion compared to standard wording in melanoma trial Standard Digital Reminders Work Well for Melanoma Monitoring Tasks
This randomized study within a trial (SWAT) of 260 participants in a melanoma surveillance program found that motivation-informed digital re…
New research shows that standard digital reminders are just as effective as motivation-based ones for helping patients complete melanoma mon…
Narrowband UVB remains first-line phototherapy for vitiligo, with JAK inhibitors emerging as adjuncts
Rheumatology Sys. Review
Narrowband UVB remains first-line phototherapy for vitiligo, with JAK inhibitors emerging as adjuncts New light therapies and skin grafts offer hope for vitiligo patients
This narrative review synthesizes current evidence on phototherapy for vitiligo, highlighting narrowband UVB as the mainstay. Excimer lasers…
A review of treatments for vitiligo highlights options like narrowband ultraviolet B light, excimer therapy, and cellular grafting that may …
Meta-analysis finds modest melanoma risk increase among infertile women using fertility treatments
Oncology Meta-analysis
Meta-analysis finds modest melanoma risk increase among infertile women using fertility treatments Fertility Drugs Linked to Slight Rise in Melanoma Risk
This systematic review and meta-analysis evaluated melanoma incidence in infertile women exposed to fertility treatments compared to untreat…
A large review finds fertility drugs may raise melanoma risk slightly, but the increase is small and more research is needed.
TIL therapy and engineered viral vector immunotherapies show pooled ORR of 37.8% in advanced melanoma
Oncology Meta-analysis
TIL therapy and engineered viral vector immunotherapies show pooled ORR of 37.8% in advanced melanoma First new analysis in years shows TIL therapy response rates for advanced melanoma
This Bayesian meta-analysis synthesizes data from 13 eligible studies on TIL therapy and engineered viral vector immunotherapies for advance…
A Bayesian meta-analysis of 13 studies finds TIL therapy yields a 49% response rate in advanced melanoma, with moderate certainty for respon…
Systematic Review: Intercellular Mitochondrial Transfer in Melanoma Progression and Resistance
Oncology Sys. Review
Systematic Review: Intercellular Mitochondrial Transfer in Melanoma Progression and Resistance Mitochondrial Transfer Fuels Melanoma Resistance and Spread
This systematic review examines the role of intercellular mitochondrial transfer in melanoma. The authors find that this process contributes…
A systematic review reveals that intercellular mitochondrial transfer helps melanoma resist therapies and spread, but may also suppress tumo…